Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Information - Accrued Expenses (Details)

v3.22.2
Balance Sheet Information - Accrued Expenses (Details) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Balance Sheet Information    
Executive Severance $ 896,524 $ 200,605
Payroll and Benefits 362,736 737,365
Professional Fees 313,853 194,425
Clinical Trials 58,287 168,785
Other   28,961
Total Accrued Expenses $ 1,631,400 $ 1,330,141